Delivery Order SPE2DB24D2018-SPE2DB25FWWW0
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency to supply OFEV 150 mg capsules (60-count units). The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, utilizes firm fixed-price pricing under a competitive, non-set-aside contract. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 Firm Fixed Price Delivery Order contract is for the supply of OFEV 150 MG CAPSULE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a potential value of $7,905.56. The contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of OFEV 150 mg on September 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,630.28, is for the supply of OFEV 100 MG CAPSULE 60S, a specialty medication. The contract has an ultimate completion date of April 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,181.16 delivery order contract is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,905.56 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This order is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,905.56 to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of OFEV 150 mg capsules. This contract has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $39,527.80 firm fixed price delivery order is for the supply of OFEV 150 MG capsules. The contract has an ultimate completion date of November 26, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has a potential value of $7,905.56 and a completion date of March 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a total potential value of...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWW0Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency (DLA) for the supply of OFEV 150 mg capsules (60-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of October 9, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant responsibility for federal medical procurement through its DLA contract portfolio. The company's extensive contract awards with the DLA Medical Supply Chain demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. All of the company's reviewed contract awards have been non-set-aside and competitively awarded, reflecting its ability to meet federal procurement requirements in the open market. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/18/25 |